Calculation of Filing Fee Table
Form S-8
(Form Type)
Rapid Micro Biosystems, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | |
| | | | | | | |
| Security Type | Security
Class Title | Fee
Calculation
Rule | Amount
Registered(1) | Proposed
Maximum
Offering
Price Per
Unit(2) | Maximum Aggregate Offering Price(2) | Fee Rate | Amount of
Registration
Fee |
| | | | | | | |
| Equity | Class A common Stock, par value $0.01 per share | Rule 457(c)
and Rule
457(h) | 330,000 shares(3) | $0.94 | $310,200 | 0.00011020 | $34.18 |
| | | | |
| Total Offering Amounts | | $310,200 | | $34.18 |
| | | | |
| Total Fee Offsets | | | | — |
| | | | |
| Net Fee Due | | | | $34.18 |
(1) Pursuant to Rule 416(a) and Rule 416(b) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover additional shares of the Registrant’s Class A common stock, par value $0.01 per share (“Common Stock”), which become issuable under the Registrant’s 2023 Inducement Plan (the “2023 Plan”) by reason of any stock split, stock dividend, recapitalization, or other similar transaction.
(2) Estimated solely for the purpose of computing the registration fee and based on the average high and low sale prices of the Common Stock as reported on the Nasdaq Global Select Market on May 3, 2023 in accordance with Rule 457(c) and (h) under the Securities Act.
(3) Represents the number of shares of Common Stock available for issuance under the Registrant’s 2023 Inducement Plan.
